Latest News

Rapid-acting antidepressant for treatment-resistant depression: New insights

Researchers have generated fresh insights that could aid in the development of rapid-acting antidepressants for treatment-resistant depression. The researchers found that by blocking NMDA receptors with the drug ketamine, they could elicit rapid antidepressant effects in patients with treatment-resistant depression. Ketamine was developed as an anesthetic, but is better known publicly for its abuse as the party drug Special K. Researchers are now seeking alternatives because ketamine can produce side effects that include hallucinations and the potential for abuse -- limiting its utility as an antidepressant.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Protein glue shows potential for use with biomaterials

  • Respiratory infection controls being used for Ebola patients are unnecessary, may contribute to public panic

  • Obese or overweight teens more likely to become smokers

  • Evidence mounting that older adults who volunteer are happier, healthier

  • Training your brain to prefer healthy foods

  • No cookie-cutter divorces, so what info should online co-parenting classes offer?

  • Healthy working environment is a salvation

  • Warm thanks: Gratitude can win you new friends

  • Learning to read: Tricking the brain

  • Meaningful relationships can help you thrive

  •